UBS ASSET MANAGEMENT AMERICAS INC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 246 filers reported holding KARUNA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.7%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,693,224
+7.3%
157,864
+15.2%
0.01%0.0%
Q2 2023$24,880,6850.0%136,9780.0%0.01%0.0%
Q1 2023$24,880,685
+16.4%
136,978
+25.9%
0.01%
+9.1%
Q4 2022$21,381,560
-99.9%
108,812
+3.1%
0.01%
-15.4%
Q3 2022$23,742,035,000
+13.9%
105,553
-35.9%
0.01%
+18.2%
Q2 2022$20,837,336,000
-32.4%
164,709
-32.3%
0.01%
-15.4%
Q1 2022$30,838,626,000
-2.1%
243,226
+1.2%
0.01%
+8.3%
Q4 2021$31,498,033,000
+18.9%
240,443
+11.0%
0.01%
+9.1%
Q3 2021$26,492,153,000
+1.1%
216,563
-5.8%
0.01%0.0%
Q2 2021$26,203,679,000
-5.4%
229,877
-0.2%
0.01%
-8.3%
Q1 2021$27,702,796,000
+9.8%
230,415
-7.2%
0.01%0.0%
Q4 2020$25,237,496,000
+45.2%
248,425
+10.5%
0.01%
+33.3%
Q3 2020$17,378,984,000
-30.7%
224,767
-0.1%
0.01%
-40.0%
Q2 2020$25,078,612,000
+118.5%
225,001
+41.1%
0.02%
+87.5%
Q1 2020$11,478,456,000159,4230.01%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$169,578,43555.90%
Nan Fung Group Holdings Ltd 225,688$48,940,44331.28%
Sofinnova Investments, Inc. 1,381,149$299,502,16119.62%
Paradigm Biocapital Advisors LP 283,605$61,499,7444.75%
First Light Asset Management, LLC 208,746$45,266,5703.55%
Avidity Partners Management LP 442,200$95,891,0703.35%
CATALYST PRIVATE WEALTH, LLC 21,837$4,735,3532.97%
Rock Springs Capital Management LP 493,527$107,021,3302.55%
Boxer Capital, LLC 250,000$54,2132.51%
DAFNA Capital Management LLC 42,173$9,145,2152.50%
View complete list of KARUNA THERAPEUTICS INC shareholders